August 2012
-
Recipharm has announced the launch of an integrated OINDP services program called Inhalation Solutions which covers development of MDIs, DPIs, and nasal sprays from early analytical services to scale up and commercial manufacturing. In June… Read more . . .
-
Verona Pharma said that it has initiated a Phase 2b dose-ranging study of RPL554 nebulized ensifentrine for the treatment of COPD, with results expected by the end of 2019. The company, which reported positive results… Read more . . .
-
According to Vectura, a jury has found that US sales of several of GlaxoSmithKline’s Ellipta DPIs infringed on Vectura’s US patent 8303991 (“Method of making particles for use in a pharmaceutical composition”). The jury awarded… Read more . . .
-
GlaxoSmithKline and Innoviva have announced that the Phase 3 CAPTAIN (Clinical study of Asthma Patients receiving Triple therapy through A single INhaler) study comparing the Trelegy Ellipta fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) DPI to the Relvar/Breo Ellipta… Read more . . .
-
Submit abstracts for oral and poster presentations by 12 July 2019 at https://aerosol-soc.com/abstract-submission/ Abstract guidelines can be found at https://aerosol-soc.com/assets/uploads/2018/12/DDL-Abstract-Guidelines-2019-1.docx Themes for DDL2019 are: FUTURE OF THE PLANET: Pollution and the environment FUTURE PREDICTIONS: Patients and Personalisation… Read more . . .
-
Submit an application or nominate someone for the DDL Emerging Scientist Award by June 30, 2019. The winner will receive a £1,000 prize and will speak at DDL 2019. According to DDL, applicants or nominees… Read more . . .
-
Intertek has acquired a a new 20,000 sq. ft facility in Melbourn, UK, doubling the size of its existing laboratory facilities at that location, the company said. As part of the expansion, Intertek said, the… Read more . . .
-
3M Drug Delivery Systems has announced that it is manufacturing the authorized generic of Proventil HFA that was recently launched by Par Pharmaceutical. Proventil HFA, which is also manufactured by 3M, is marketed by Merck.… Read more . . .
-
Nanoform has announced the appointment of former GSK Particle Size Reduction Lead David Rowe as Head of Manufacturing. In December 2018, the Finnish nanotechnology company announced the construction of a new GMP manufacturing facility in… Read more . . .
-
According to Glenmark Pharmaceuticals, the Russian Ministry of Healthcare has approved the company’s Momate Rhino mometasone furoate nasal spray for over-the-counter sales for the treatment of allergic rhinitis in adults. Glenmark Pharmaceuticals Senior VP and… Read more . . .
Featured event:
5th Annual Inhaled & Nasal Biologics | DNA Forum
5th Annual Inhaled & Nasal Biologics | DNA Forum
24th-25th September 2026, Cambridge, UK
Join us for a ground-breaking and insightful forum: Two days of cutting-edge talks and networking opportunities in this complex area of drug and vaccine development.
With renowned industry leaders who will share their insights and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don’t miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics.
Get online to see speakers announced so far. Registration is live – save your seat now!
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.